David Eidelberg
Imaging in Parkinson's Disease
David Eidelberg
Imaging in Parkinson's Disease
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Imaging in Parkinson's Disease provides up-to-date information concerning new applications of brain imaging to the study of Parkinson's disease. Written by experts in the field, the book focuses on structural and functional imaging methodologies that have recently been applied to study the natural history of Parkinson's disease.
Andere Kunden interessierten sich auch für
- Non-Dopamine Lesions in Parkinson's Disease227,99 €
- Orlando OrtizImaging of the Postoperative Spine, an Issue of Neuroimaging Clinics117,99 €
- Allan Hugh ColeCounseling Persons with Parkinson's Disease53,99 €
- Alexander I TrosterClinical Neuropsychology and Cognitive Neurology of Parkinson's Disease and Other Movement Disorders222,99 €
- Suyash MohanBrain Imaging Case Review84,99 €
- Joseph R GrajoAbdominal Imaging118,99 €
- Jacques FantiniBrain Lipids in Synaptic Function and Neurological Disease134,99 €
-
-
-
Imaging in Parkinson's Disease provides up-to-date information concerning new applications of brain imaging to the study of Parkinson's disease. Written by experts in the field, the book focuses on structural and functional imaging methodologies that have recently been applied to study the natural history of Parkinson's disease.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Hurst & Co.
- Seitenzahl: 222
- Erscheinungstermin: 30. August 2011
- Englisch
- Abmessung: 279mm x 213mm x 20mm
- Gewicht: 939g
- ISBN-13: 9780195393484
- ISBN-10: 0195393481
- Artikelnr.: 33372832
- Verlag: Hurst & Co.
- Seitenzahl: 222
- Erscheinungstermin: 30. August 2011
- Englisch
- Abmessung: 279mm x 213mm x 20mm
- Gewicht: 939g
- ISBN-13: 9780195393484
- ISBN-10: 0195393481
- Artikelnr.: 33372832
David Eidelberg received his MD from Harvard Medical School in 1981. After completing residency training in neurology at Harvard, he pursued fellowship training in functional brain imaging research in London and New York. He is currently Head of the Center for Neurosciences at The Feinstein Institute for Medical Research. He is also director of the new NIH Morris K. Udall Center for Parkinson's Disease Research and Susan and Leonard Feinstein Professor of Neuroscience at The Feinstein Institute. He also serves on the editorial boards of several major journals including Annals of Neurology and is Associate Editor of The Journal of Neuroscience .
* Contributors
* Chapter 1: Dopaminergic Imaging in Parkinson's DiseaseD: PET, A. Jon
Stoessl and Biju Gopalakrishnan
* Chapter 2: Dopaminergic Imaging in Parkinson's DiseaseD: SPECT,
Christoph Scherfler and Werner Poewe
* Chapter 3: Cerebral Glucose Metabolism and Blood Flow in Parkinson's
Disease, Yilong Ma, Schichun Peng, Vijay Dhawan, and David Eidelberg
* Chapter 4: Structural Abnormalities in Parkinson's Disease: MRI and
Related Methods, Kathrin Reetz and Ferdinand Binkofski
* Chapter 5: Transcranial Sonography in Parkinsonian Syndromes, Daniela
Berg
* Chapter 6: Parkinsonian Tremor, Ioannis U. Isaias and Angelo Antonini
* Chapter 7: Atypical Parkinsonian Syndromes, Kathleen L. Poston
* Chapter 8: Brain Activation Studies in Parkinson's Disease, L.K.
Prashanth and Antonio P. Strafella
* Chapter 9: Functional Markers of Cognition in Parkinson's Disease:
18F-FDG and H215O Positron Emission Tomography Studies, Paul Mattis
and Maren Carbon
* Chapter 10: Imaging Cognitive Dysfunction in Parkinson's Disease:
Cholinergic Neurotransmission and Protein Aggregation, Nicholaas I.
Bohnen and Kirk A. Frey
* Chapter 11: Imaging Inflammation in Parkinsonian Syndromes, David J.
Brooks
* Chapter 12: Functional Imaging Biomarkers for the Assessment of
Parkinson's Disease Progression, Chris C. Tang and David Eidelberg
* Chapter 13: Effects of Treatment: Pharmacologic, Alain Dagher
* Chapter 14: Neuroimaging in Levodopa Induced Dyskinesia, Shigeki
Hirano
* Chapter 15: Effects of Surgical Treatment, Anna L. Bartels and Klaus
L. Leenders
* Chapter 16: Cell-Based Therapies: Imaging Outcomes, Paola Piccini and
Marios Politis
* Chapter 17: Imaging Applications to Parkinson's Disease Clinical
Trials, Martin Niethammer and Andrew Feigin
* Chapter 18: Clinical Applications, Kathleen L. Poston
* Chapter 1: Dopaminergic Imaging in Parkinson's DiseaseD: PET, A. Jon
Stoessl and Biju Gopalakrishnan
* Chapter 2: Dopaminergic Imaging in Parkinson's DiseaseD: SPECT,
Christoph Scherfler and Werner Poewe
* Chapter 3: Cerebral Glucose Metabolism and Blood Flow in Parkinson's
Disease, Yilong Ma, Schichun Peng, Vijay Dhawan, and David Eidelberg
* Chapter 4: Structural Abnormalities in Parkinson's Disease: MRI and
Related Methods, Kathrin Reetz and Ferdinand Binkofski
* Chapter 5: Transcranial Sonography in Parkinsonian Syndromes, Daniela
Berg
* Chapter 6: Parkinsonian Tremor, Ioannis U. Isaias and Angelo Antonini
* Chapter 7: Atypical Parkinsonian Syndromes, Kathleen L. Poston
* Chapter 8: Brain Activation Studies in Parkinson's Disease, L.K.
Prashanth and Antonio P. Strafella
* Chapter 9: Functional Markers of Cognition in Parkinson's Disease:
18F-FDG and H215O Positron Emission Tomography Studies, Paul Mattis
and Maren Carbon
* Chapter 10: Imaging Cognitive Dysfunction in Parkinson's Disease:
Cholinergic Neurotransmission and Protein Aggregation, Nicholaas I.
Bohnen and Kirk A. Frey
* Chapter 11: Imaging Inflammation in Parkinsonian Syndromes, David J.
Brooks
* Chapter 12: Functional Imaging Biomarkers for the Assessment of
Parkinson's Disease Progression, Chris C. Tang and David Eidelberg
* Chapter 13: Effects of Treatment: Pharmacologic, Alain Dagher
* Chapter 14: Neuroimaging in Levodopa Induced Dyskinesia, Shigeki
Hirano
* Chapter 15: Effects of Surgical Treatment, Anna L. Bartels and Klaus
L. Leenders
* Chapter 16: Cell-Based Therapies: Imaging Outcomes, Paola Piccini and
Marios Politis
* Chapter 17: Imaging Applications to Parkinson's Disease Clinical
Trials, Martin Niethammer and Andrew Feigin
* Chapter 18: Clinical Applications, Kathleen L. Poston
* Contributors
* Chapter 1: Dopaminergic Imaging in Parkinson's DiseaseD: PET, A. Jon
Stoessl and Biju Gopalakrishnan
* Chapter 2: Dopaminergic Imaging in Parkinson's DiseaseD: SPECT,
Christoph Scherfler and Werner Poewe
* Chapter 3: Cerebral Glucose Metabolism and Blood Flow in Parkinson's
Disease, Yilong Ma, Schichun Peng, Vijay Dhawan, and David Eidelberg
* Chapter 4: Structural Abnormalities in Parkinson's Disease: MRI and
Related Methods, Kathrin Reetz and Ferdinand Binkofski
* Chapter 5: Transcranial Sonography in Parkinsonian Syndromes, Daniela
Berg
* Chapter 6: Parkinsonian Tremor, Ioannis U. Isaias and Angelo Antonini
* Chapter 7: Atypical Parkinsonian Syndromes, Kathleen L. Poston
* Chapter 8: Brain Activation Studies in Parkinson's Disease, L.K.
Prashanth and Antonio P. Strafella
* Chapter 9: Functional Markers of Cognition in Parkinson's Disease:
18F-FDG and H215O Positron Emission Tomography Studies, Paul Mattis
and Maren Carbon
* Chapter 10: Imaging Cognitive Dysfunction in Parkinson's Disease:
Cholinergic Neurotransmission and Protein Aggregation, Nicholaas I.
Bohnen and Kirk A. Frey
* Chapter 11: Imaging Inflammation in Parkinsonian Syndromes, David J.
Brooks
* Chapter 12: Functional Imaging Biomarkers for the Assessment of
Parkinson's Disease Progression, Chris C. Tang and David Eidelberg
* Chapter 13: Effects of Treatment: Pharmacologic, Alain Dagher
* Chapter 14: Neuroimaging in Levodopa Induced Dyskinesia, Shigeki
Hirano
* Chapter 15: Effects of Surgical Treatment, Anna L. Bartels and Klaus
L. Leenders
* Chapter 16: Cell-Based Therapies: Imaging Outcomes, Paola Piccini and
Marios Politis
* Chapter 17: Imaging Applications to Parkinson's Disease Clinical
Trials, Martin Niethammer and Andrew Feigin
* Chapter 18: Clinical Applications, Kathleen L. Poston
* Chapter 1: Dopaminergic Imaging in Parkinson's DiseaseD: PET, A. Jon
Stoessl and Biju Gopalakrishnan
* Chapter 2: Dopaminergic Imaging in Parkinson's DiseaseD: SPECT,
Christoph Scherfler and Werner Poewe
* Chapter 3: Cerebral Glucose Metabolism and Blood Flow in Parkinson's
Disease, Yilong Ma, Schichun Peng, Vijay Dhawan, and David Eidelberg
* Chapter 4: Structural Abnormalities in Parkinson's Disease: MRI and
Related Methods, Kathrin Reetz and Ferdinand Binkofski
* Chapter 5: Transcranial Sonography in Parkinsonian Syndromes, Daniela
Berg
* Chapter 6: Parkinsonian Tremor, Ioannis U. Isaias and Angelo Antonini
* Chapter 7: Atypical Parkinsonian Syndromes, Kathleen L. Poston
* Chapter 8: Brain Activation Studies in Parkinson's Disease, L.K.
Prashanth and Antonio P. Strafella
* Chapter 9: Functional Markers of Cognition in Parkinson's Disease:
18F-FDG and H215O Positron Emission Tomography Studies, Paul Mattis
and Maren Carbon
* Chapter 10: Imaging Cognitive Dysfunction in Parkinson's Disease:
Cholinergic Neurotransmission and Protein Aggregation, Nicholaas I.
Bohnen and Kirk A. Frey
* Chapter 11: Imaging Inflammation in Parkinsonian Syndromes, David J.
Brooks
* Chapter 12: Functional Imaging Biomarkers for the Assessment of
Parkinson's Disease Progression, Chris C. Tang and David Eidelberg
* Chapter 13: Effects of Treatment: Pharmacologic, Alain Dagher
* Chapter 14: Neuroimaging in Levodopa Induced Dyskinesia, Shigeki
Hirano
* Chapter 15: Effects of Surgical Treatment, Anna L. Bartels and Klaus
L. Leenders
* Chapter 16: Cell-Based Therapies: Imaging Outcomes, Paola Piccini and
Marios Politis
* Chapter 17: Imaging Applications to Parkinson's Disease Clinical
Trials, Martin Niethammer and Andrew Feigin
* Chapter 18: Clinical Applications, Kathleen L. Poston